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Abstract
Background: Long Interspersed Nuclear Element-1 (L1) is an oncogenic mammalian retroelement silenced early in
development via tightly controlled epigenetic mechanisms. We have previously shown that the regulatory region of
human and murine L1s interact with retinoblastoma (RB) proteins to effect retroelement silencing. The present
studies were conducted to identify the corepressor complex responsible for RB-mediated silencing of L1.
Methods: Chromatin immunoprecipitation and silencing RNA technology were used to identify the repressor
complex that silences L1 in human and murine cells.
Results: Components of the Nucleosomal and Remodeling Deacetylase (NuRD) multiprotein complex specifically
enriched the L1 5′-untranslated DNA sequence in human and murine cells. Genetic ablation of RB proteins in
murine cells destabilized interactions within the NuRD macromolecular complex and mediated nuclear rearrangement
of Mi2-β, an ATP-dependent helicase subunit with nucleosome remodeling activity. Depletion of Mi2-β, RbAP46 and
HDAC2 reduced the repressor activity of the NuRD complex and reactivated a synthetic L1 reporter in human cells.
Epigenetic reactivation of L1 in RB-null cells by DNA damage was markedly enhanced compared to wild type cells.
Conclusions: RB proteins stabilize interactions of the NuRD corepressor complex within the L1 promoter to effect L1
silencing. L1 retroelements may serve as a scaffold on which RB builds heterochromatic regions that regulate
chromatin function.
Keywords: Chromatin, Gene silencing, Long interspersed nuclear element-1, Retinoblastoma proteins, Nucleosomal
and remodeling deacetylase complex
Background
Human L1s are non-LTR mammalian retrotransposons
that consist of an internal bidirectional promoter, two
open reading frames encoding for ORF1p (RNA-binding
protein) and ORF2p (reverse transcriptase and endonucle-
ase activities), a 3′- untranslated region (UTR), and a
polyA tail [1]. Murine L1s share similar structural and
functional features, except that the 5′-UTR is organized
into monomeric units that function as an upstream
promoter [2]. While L1s are highly active during early em-
bryonic development, they are targeted for epigenetic
silencing via DNA methylation and histone covalent mod-
ifications during the course of differentiation [3]. L1 re-
activation is strongly associated with the acquisition of
oncogenic phenotypes resulting from insertion mutagen-
esis and/or reprogramming of gene expression [1].
We have previously shown that recruitment of E2F/RB
(E2F-retinoblastoma) to the L1 promoter, along with his-
tone deacetylases 1 and 2 (HDAC1 and HDAC2, respect-
ively) [4, 5] and methyl binding protein 2 (MBD2) [5] are
critical to L1 silencing. Mouse embryo fibroblasts (MEFs)
lacking all RB family members (pRb, p107, and p130) and
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referred to as triple knockout (TKO) MEFs, show im-
paired recruitment of HDACs to the L1 promoter and
markedly enhanced L1 expression compared to wild type
MEFs. Methyl CpG binding protein 2 (MeCP2) represses
the transcriptional activity of L1 in transient reporter as-
says [6] and in vivo [7], and this activity is related to
HDAC recruitment to methylated DNA [8]. The identity




MCF7 cells, HeLa cells, primary mouse embryo fibroblasts
(MEFs) and RB null MEFs lacking all three family members
(RB, p105 and p107) (TKO) were cultured in Dulbecco’s
Modified Eagle’s medium (MultiCel; Cytosystems Pty. Ltd.,
Castle Hill, NSW, Australia) supplemented with 10 % fetal
calf serum (FCS), 200 mg/ml streptomycin, and 200 U/ml
penicillin G at 5 % CO2 and humidified air at 37 °C.
Quantitative real time PCR
Total RNA was extracted and 1 μg used for cDNA synthe-
sis (Invitrogen Superscript II). For each reaction, 25 μL of
2X SYBR green (Biorad) was mixed with forward and re-
verse primers to give a final concentration of 10 μm. One
μL of cDNA mixture was brought up to 50 μL using DEPC
water. Cycling conditions included an initial denaturation
at 95 °C for 3 min followed by 50 cycles at 95 °C for 30 s,
55 °C for 30 s and 72 °C for 45 s. The homogeneity of PCR
products was confirmed using a real time PCR melting
curve.
Chromatin immunoprecipitation
Cells were grown in 150 mm petri dishes to 90 % conflu-
ence, fixed in 1 % formaldehyde for 7 min and rinsed 3X
with cold PBS. Chromatin was sheared to fragments
below 1 Kb and 20 μg immunoprecipitated using se-
lected antibodies. After purification, 0.5 to 2.0 μL of
DNA were used for PCR. DNA from non-precipitated
chromatin samples was extracted and used as input for
PCR. Controls included isotype-matched IgG or Mock
reactions which included all reagents except chromatin.
Indirect immunofluorescence
Cells were grown on glass coverslips to 30 % confluence,
rinsed 2X with PBS (phosphate-buffered saline, pH 7.4),
fixed in 3 % paraformaldehyde for 15 min at 4 °C and
rinsed twice with PBS. Fixed cells were permeabilized with
0.1 % Triton-X100 for 5 min, blocked in 2 % dry milk for
15 min, rinsed with PBS twice and incubated with primary
antibody (anti-Mi2-β, ABCAM, MA) in PBS containing 1
% dry milk and 0.1 % Triton-X100 overnight. Secondary
antibody, mouse mAB-Alexa-488 conjugate, was incu-
bated for 1 h at room temperature. Cells were washed 3X
with PBS and incubated in 1 μg/ml Hoescht nuclear dye
for 20 min and then washed twice. Cells were visualized in
a CARL ZEISS AXIOVERT 200 inverted microscope at a
magnification of 63X.
Protein immunoprecipitation
Cells were lysed with buffer and centrifuged at 4000 rpm
for 2 min. Immunoprecipitation using anti-Mi-2β and
anti-RbAp46 were completed as described previously [4].
RNA interference assays
Cells were transfected with an EGFP-tagged L1RP vec-
tor. After the disappearance of EGFP fluorescence by
epigenetic silencing, cells were replated and treated at
30-50 % confluence with 4 nM siRNA for 48 h followed
by direct measurements of fluorescence.
Chemical treatments
Cells were challenged with 3 μM BaP or 0.06 % dimethyl
sulfoxide (DMSO) as vehicle control for 16 h to reacti-
vate L1.
Ethics statement
No ethics approval was required for the experimental
work performed in this study.
Results
The NuRD corepressor complex is recruited to the L1
promoter
The NuRD multiprotein complex includes the
dermatomyositis-specific Mi2 autoantigen (Mi2-β),
RB-associated proteins 46 and 48 (RbAp46 and RbAp48),
MBD2 and MBD3, and metastasis-associated proteins 2
and 3 (MTA2 and MTA3) [9–11]. Validation trials were
completed using soluble chromatin of human MCF7 cells
and antisera against components of the NuRD corepressor
complex compared to rabbit IgG as a control for non-
specific interactions. Snail, a master switch for epithelial-
to-mesenchymal transition in breast cancer that is regu-
lated by the Mi2-β/NuRD complex [12], was used as a
positive control in these experiments. As expected, spe-
cific enrichment for NuRD proteins on the Snail promoter
was observed (Fig. 1a). PCR amplification of the human
L1RP 5′-UTR was compared to Snail and glucose 6-
phosphate dehydrogenase (G6PD) gene promoters as
positive and negative control sequences, respectively. All
NuRD subunits specifically enriched the sample for the
human L1RP 5′-UTR DNA sequence, but not the G6PD
sequence (Fig. 1b). The presence of MBD3, MTA2 and
MTA3 readily identified the complex as the MeCP1 multi-
protein complex. The NuRD complex is involved in re-
modeling of nucleosomal particles to mediate formation
of heterochromatin and localized domains of repressive
chromatin. Mi2-β functions as an ATP-dependent helicase
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subunit with nucleosome remodeling activity [13], while
RbAp46 functions as an adaptor subunit that recruits
HDAC and inhibits HDAC-independent transcription [14,
15]. MBD3 may serve as a scaffold for assembly of the
multimeric complex [16], while MTA2 and MTA3 aid in
the recruitment of HDACs1 and 2 [16].
Subsequent experiments were conducted to examine
the role of RB proteins in NuRD complex recruitment
comparing wild type MEFs to TKO MEFs in which all
three member of the RB family were genetically ablated
[5]. In these studies, we tested antisera against Mi2-β,
MBD3, MTA-2, and RbAp46/48, as well as histone H4
and a control rabbit serum. Specific enrichment for L1
5′-UTR was seen for Mi2-β, MBD2/3, MTA-2, and
RbAp46 in wild type MEFs (Fig. 1c). Immunoprecipita-
tion with total histone H4 antisera, but not control IgG
yielded high levels of L1 DNA enrichment (not shown).
In sharp contrast, markedly reduced enrichment was
seen when chromatin from TKO MEFs was immunopre-
cipitated with serum against Mi2-β, MBD2/3, or MTA-2
(Fig. 1c). This pattern of response was specific to L1 se-
quences, as evidenced by markedly different profiles of
NuRD protein recruitment to IL-4 intron 2 sequences
(Fig. 1d). A comparison with IL-4 intron 2 sequences is
pertinent given that genetic ablation of MTA-2 corre-
lates with hyperinduction of IL-4 and abnormal T-cell
activation in mice [17], and this response is partly medi-
ated by a cis-acting element located in the second intron
of the murine IL-4 gene [18]. As such, promoter specific
patterns of RB-mediated regulation of L1 were identified.
Together, these findings indicate that both human and
murine L1 retroelements target the NuRD complex to
their promoter regions, with RB proteins likely serving
as stabilizers of macromolecular interactions.
Silencing of NuRD subunits reactivates L1
Since basal L1 mRNA levels are markedly upregulated in
TKO MEFs [4], we sought to compare the relative abun-
dance of NuRD corepressor proteins in wild type and
TKO MEFs. HDACs1 and 2 were overexpressed in TKO
MEFs, a finding consistent with previous reports from
the laboratory [4]. Mi2-β was expressed at higher levels
in wild type MEFs compared to RB null cells, while both
MBD2 and MBD3 were enhanced in TKO MEFs com-
pared to wild type MEFs. These findings suggest that the
stoichiometry of the NuRD protein complex is unbal-
anced in the absence of RB, a hypothesis consistent with
previous work showing that a reduction in Mi2 is para-
mount to histone-regulated nucleosome rearrangements
[19]. Mi2-β was detected almost exclusively in the nu-
cleus of WT MEF cells, while TKO MEFs showed Mi2-β
localization in both the nuclear and cytoplasmic com-
partments, with punctate signal readily detected near the
periphery of the cells (Fig. 2b). Relative decreases in nu-
clear localization of Mi2-β were confirmed by Western
blotting using fractionated cytosolic and nuclear extracts
from wild type and TKO MEFs (Fig. 2c). No signal was
detected in the cytosolic fraction of either wild type or
TKO MEFs, a finding consistent with the observation
that delocalized Mi2-β associates with the plasma mem-
brane (Fig. 2b). Immunoprecipitation of NuRD protein
components using antibodies against Mi2-β (Fig. 2e) or
Fig. 1 The NuRD co-repressor interacts with the human and murine
L1 promoters in vivo. MCF7 breast cancer cells and early passage
MEF cells were grown to 90 % confluence, crosslinked with DTBP
and then treated with 1 % formaldehyde. Solubilized chromatin was
immunoprecipitated using selected antibodies and amplified for the
known MeCP1 target promoter Snail a, the human L1 promoter b,
the murine L1Md-A type promoter c and the human IL-4 intron 2
transcriptional enhancer (d). Panel (a) shows two replicates for each
for Mi2-β, MTA2, RbAp46/48, MBD3, MTA3 and IgG. Panel (c) shows
the average of three separate chromatin immunoprecipitation assays
for NuRD constituent proteins in WT and RB null MEFs (TKO). PCR
products were separated in a 1 % agarose gel and visualized using a
KODAK imager U.V. station. The results of three different experiments
established the interaction of NuRD constituent proteins with the L1
promoter and implicated RB proteins in this process. Statistical
differences for non-parametric data were evaluated using the
Mann–Whitney test
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RbAp46 (Fig. 2e) confirmed critical protein-protein
interactions.
To test for functional changes in L1 regulation, siRNA
silencing of NuRD subunit components was examined
next. HeLa cells were transfected with a vector encoding
the full length human L1RP carrying a chimeric ORF1p-
GFP fusion protein. The backbone vector, pGL4.13,
lacked an episomal sequence and is known to undergo
silencing upon integration, as evidenced by the loss of
fluorescence (Fig. 3). Transfected cells were then treated
with a mixture of siRNAs directed against target and
non-target siRNAs and fluorescence measured after 48
h. In keeping with earlier findings, we selected Mi2-β
due to its importance in nucleosomal displacement,
RbAp46 for its interaction with the pocket domain of RB
proteins and HDAC1 for its role in silencing of core his-
tones. In these experiments, HeLa cells were seeded at
low densities to account for long latencies during re-
peated transfection and the efficiency of genetic knock-
down confirmed by Western blotting (not shown).
Figure 3 shows that non-target siRNA treatment did not
change the repressive state of ectopic L1, as evidenced
Fig. 2 Recruitment of the NuRD corepressor complex in MEFs is influenced by RB proteins. a Wild type and TKO MEFs were grown to 90 %
confluence, trypsinized and lysed using RIPA buffer supplemented with protease inhibitors. 20 μg of total protein was separated on a 4-12 % gradient
PAGE gel and probed with antisera against selected targets. HRP-linked secondary antibodies were used for protein detection. Film exposure times varied
from 30 s to 3 min. The abundance of Mi2-β was dramatically reduced in MEFs lacking RB proteins, while other members of the NuRD
corepressor complex including, HDAC1, HDAC2 and MBD3, were increased. No differences in LDH levels and Ponceau staining as loading
controls were observed. These results are representative of three independent experiments. b Immunofluorescence staining for Mi2-β and
DAPI in WT and TKO MEFs. The signal in WT MEFs was confined to the nucleus, while that in TKO MEFs was distributed throughout the
cell thus giving rise to lighter fluorescence signals. c Measurement of Mi2-b levels by Western blot analysis in nuclear extracts (NE) and cytosolic extracts
(CE) of wild type and TKO MEFs. Lamin B2 and LDH were used as markers of purity for the nuclear and cytosolic extracts, respectively. Ponceau staining
was used as a loading control for each of the fractions. While decreased nuclear Mi2-β levels as evidenced by Western blot analysis of nuclear protein in
TKO cells compared to wildtype counterparts was observed, no signal was detected in the cytoplasmic fraction. d Immunoprecipitation of RbAp46 using
anti-Mi2-β antibody in NE of WT MEFs. e Immunoprecipitation of MTA2, Mi2-β, and HDAC2 using anti-RbAp46 antibody in NE of WT and TKO MEFs
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by the continued absence of fluorescence. Targeting of
Mi2-β, RbAP46, and HDAC1 reactivated ORF1p-GFP ex-
pression, as evidenced by the reappearance of fluorescence
signal. Of interest was the finding that treatment of cells
with target siRNAs caused dramatic changes in cellular
morphology. These findings indicate that disruption of the
NuRD complex is sufficient to induce L1 reactivation.
RB deficiency leads to unregulated L1 retroelement
reactivation
To examine the functionality of NuRD complexes in RB-
deficient cells, we challenged wild type and TKO cells for
16 h with benzo(a)pyrene (BaP), a genotoxic carcinogen
that reactivates L1 via epigenetic mechanisms [5]. BaP
induces early enrichment of transcriptionally-active chro-
matin markers and reduces the association of DNA
methyltransferase-1 (DNMT1) with the L1 promoter.
These changes are followed by proteasome-dependent de-
creases in cellular DNMT1 and sustained reduction of
cytosine methylation within the L1 promoter CpG island.
Compared to DMSO controls, L1 expression increased in
wild type MEFs challenged with the carcinogen (Fig 4),
while two independent clones of TKO MEFs showed re-
markable enhancement of the L1 response (Fig 4). Inter-
estingly, the responsiveness of TKOμ was enhanced
compared to its counterpart mutant line, but the origin of
Fig. 3 siRNA targeting of NuRD subunits reactivates ectopic L1. HeLa cells were transfected with a synthetic human L1 retroelement cloned into
a pGL4.13 backbone vector where L1 ORF1p was tagged with EGFP fluorescent protein as a marker of reactivation. Following transfection, cells
were grown for 7 days until no fluorescence was detected due to epigenetic silencing. Cells were then transfected with a mixture of siRNAs
targeting Mi2-β, RbAp46 and HDAC1 compared to a non-target scrambled sequence. Images were acquired 48 h post transfection. Each experiment
was performed in triplicate and images shown representative of the respective fields
Fig. 4 Genotoxic injury in the absence of the RB proteins leads to
markedly upregulated L1 expression. Wild type MEFs and two
independent TKO MEF clones were grown in 10 cm plates to 90 %
confluence and treated with either medium alone, 0.06 % DMSO
vehicle or 3 μM B(a)P for 16 h. Total RNA was extracted, quantified
and cDNA prepared from 1 μg of starting material. 5 μL of a 1:20
dilution of the cDNA synthesis reaction were employed in qPCR
studies with primers against β actin or murine L1 ORF1. Relative
quantitative analyses were done using the Livak method of DDCt.
Each experiment was performed at least three independent times
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these differences in response have not been investigated.
These data show that RB deficiency leads to unregulated
L1 reactivation which combined with other findings indi-
cate that L1 silencing in somatic cells is effected through
interactions between RB family members and proteins
within the NuRD macromolecular complex.
Discussion
The NuRD complex represents a multiprotein complex
that mediates formation of heterochromatin and local-
ized domains of repressive chromatin. Its repressor
activity involves assembly of a histone deacetylase
macromolecular complex that couples histone modifi-
cations with nucleosome-stimulated ATPase activity.
Mi2-β, RbAp46, MBD3, MTA 2 and MTA3 have been
identified as critical NuRD multiprotein complex com-
ponents. Mi2-β functions as an ATP-dependent heli-
case [13], RbAp46 recruits HDAC and inhibits HDAC-
independent transcription [14, 15], MBD3 serves as a
scaffold for complex assembly [16] and MTAs cooper-
ate in the recruitment of HDACs [16].
The epigenetic silencing profile executed by the NuRD
complex includes histone deacetylation, histone H3 ly-
sine K9, H3 lysine 27, and H4 lysine 20 trimethylation,
and DNA methylation, which together contribute to the
recruitment of non-coding RNAs and repressors and co-
repressors to induce facultative or constitutive hetero-
chromatin formation [20]. In this context, it is important
to note that the polycomb repressive complex 2 (PRC2)
mediates H3K27 methylation, which in turn facilitates
PRC1 binding to methylated H3K27 and PRC1-dependent
chromatin compaction [21]. Genes silenced during devel-
opment are characterized by the presence of broad do-
mains of repressive chromatin containing high levels of
trimethylated H3K27 [20] or trimethylated H3K4 [22]. Re-
petitive elements such as L1 are rich in H3K9, H3K27,
and H4K20 methylation and, importantly, their methyla-
tion density defines states of cellular differentiation [23].
Thus, repression of L1 activity is likely a conserved bio-
logical mechanism to ensure maintenance of the differen-
tiated state.
Repetitive L1 sequences in the mammalian genome are
extensively silenced via DNA methylation, and L1 methy-
lation status is frequently used as a proxy of global cellular
methylation [24, 25]. This laboratory has previously shown
that BaP carcinogenesis is associated with L1 reactivation
via mechanisms that involve E2F/RB-regulated opening of
chromatin. Molecular reactivation is mediated by enrich-
ment of H3K4Me3 and H3K9Ac, increased histone H3
acetylation at or near the 5′UTR and inhibition of
DNMT1 recruitment and activity within the L1 promoter
[4, 5]. Decreased DNMT1 is associated with decreased
methylation at several CpG loci within the L1 promoter to
mediate sustained retroelement reactivation. We also
discovered that the Human Papilloma Virus (HPV) onco-
protein E7 associates with RB to differentially regulate L1
promoter activity in mammalian cells [26].
Our previous findings are consistent with the new data
showing that L1 silencing by RB proteins is effected
through the NuRD multiprotein complex. All major com-
ponents of the NuRD complex are recruited to the si-
lenced L1 promoter, and recruitment exhibits promoter-
specificity. RB appears to orchestrate the recruitment of
NuRD proteins and loss of RB function is associated with
delocalization of Mi2-β from the nuclear to the cytosolic
compartment. A critical role for RB in regulation of L1
retrotransposon was established in studies showing that
genetic ablation of RB family members is associated with
highly unregulated overexpression of L1 in MEFs. Recent
studies using non-transformed human bronchial epithelial
cells have shown that L1 reactivation by BaP is associated
with disruption of NuRD complex assembly and function
(Bojang et al. LINE 1 reactvation in human bronchial
ephitelial cells requires dissambly of NuRD multiplrotein
complex and loss or Mi2β and MBD2/3 correpressor
functions, Submitted). Similar studies using cancer cell
lines are confounded by differences in RB mutant status
and RB-related functions. Such differences notwithstand-
ing, comparative analyses of constitutive L1 expression
have shown that human cells exhibit remarkably lower ex-
pression than murine cells [27], a finding consistent with
species differences in rates of L1 retrotransposition. Im-
portantly, L1 expression is considerably reduced in non-
transformed human cells compared to transformed cells
with dysregulated RB function. In keeping with these find-
ings, Belancio et al. [28] showed that expression of full
length and processed transcripts of L1 in normal human
tissues, except possibly testis, is lower compared to trans-
formed human cell lines. Direct comparisons of trans-
formed cell lines showed that HeLa cells express lower
levels of full-length L1 than MCF7 breast cancer cells, but
that total L1-related products were comparable. The abil-
ity of transformed cell lines to support higher rates of L1
transcription, mRNA processing and retrotransposition is
consistent with documented changes in RB regulation and
function during the course of malignant transformation.
In accord with these observations, normal human bron-
chial epithelial cells carrying wildtype RB exhibit low L1
expression, with high L1 inducibility upon genetic ablation
of Mi2-β (Bojang et al. LINE 1 reactvation in human
bronchial ephitelial cells requires dissambly of NuRD
multiplrotein complex and loss or Mi2β and MBD2/3
correpressor functions, Submitted).
Collectively, our findings identify RB as a critical regula-
tor of the NuRD multiprotein repressor complex assembly
within the regulatory region of L1. NuRD recruitment is
in turn responsible for effective silencing of L1 transcrip-
tional activity. Genetic ablation of RB proteins destabilizes
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protein-protein interactions within the NuRD macromol-
ecular complex to mediate nuclear rearrangement and
delocalization of Mi2-β from the nuclear to cytoplasmic
compartment. These findings suggest that Mi2-β is critical
to transcriptional repression of L1. These findings are
highly relevant to our understanding of oncogenesis and
malignant progression given that NuRD is a key determin-
ant of cellular differentiation, and that inappropriate
recruitment of NuRD to specific loci contributes to
tumorigenesis [29]. Given that L1 promoter hypomethyla-
tion has been associated with cancers at multiple sites
[30], it is possible that NuRD-mediated oncogenesis is as-
sociated with disruption of transcriptional control of L1
retroelements. Simple inferences cannot be established
given that the pathology of altered L1 expression in cancer
involves genetic and epigenetic deficits associated with
mutational L1 insertions [31] and unregulated profiles of
gene expression [32].
Conclusions
Our findings indicate that the L1 silencing by RB is
effected through the NuRD macromolecular complex
and implicate these molecular interactions in the forma-
tion of L1 heterochromatin structures. Full-length L1s in
the mammalian genome are therefore potential targets
for NuRD-mediated silencing and recruitment of silen-
cing proteins such as the polycomb family of proteins.
As such, unregulated silencing of L1 may play a central
role in the initiation and progression of cancer.
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